Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Office of AIDS Research Advisory Council.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: Office of AIDS Research Advisory Council.
Date: October 5-6, 2000.
Time: October 5, 2000, 9 a.m. to 5 p.m.
Agenda: International research priorities to address the global AIDS pandemic and the role of the National Institutes of Health (NIH) in this critical research area.
Place: 9000 Rockville Pike, Building 31, Conference Room 10, Bethesda, MD 20892.
Time: October 6, 2000 a.m. to 12 p.m.
Agenda: Vaccine Clinical Trials.
Place: 9000 Rockville Pike, Building 31, Conference Room 10, Bethesda, MD 20892.
Contact Person: Linda Reck, Head, Program, Planning and Evaluation, Office of AIDS Research, NIH, Bethesda, MD 20892, (301) 402-8655.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program, National Institutes of Health, HHS)
Dated: September 12, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-24240 Filed 9-20-00; 8:45 am]
BILLING CODE 4140-01-M